Dr Stephan Dreyer

  • Honorary Clinical Lecturer (School of Cancer Sciences)

Research interests

Research groups

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017
Number of items: 24.

2025

Dreyer, Stephan B., Beer, Philip, Hingorani, Sunil R. and Biankin, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 (2025) Improving outcomes of patients with pancreatic cancer. Nature Reviews Clinical Oncology, 22(6), pp. 439-456. (doi: 10.1038/s41571-025-01019-9) (PMID:40329051)

Herbert, Katharine J. ORCID logoORCID: https://orcid.org/0000-0001-9437-0253, Upstill-Goddard, Rosie, Dreyer, Stephan B., Rebus, Selma, Pilarsky, Christian, Debabrata, Mukhopadhyay, Lord, Christopher J., Biankin, Andrew V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Froeling, Fieke E.M. ORCID logoORCID: https://orcid.org/0000-0002-8653-8164 and Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2025) Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma. British Journal of Cancer, (doi: 10.1038/s41416-025-03051-z) (Early Online Publication)

2024

Boey, A., Bryce, A. ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Dickson, E., Coats, M., McKay, C., Jamieson, N. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Chang, D. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078, Holroyd, D. and Dreyer, S. (2024) The Impact of Pre-operative Indeterminate Lung Nodules in the Surgical Management of Pancreatic Ductal Adenocarcinoma. 16th World Congress of the International Hepato-Pancreato-Biliary Association, Cape Town, South Africa, 15-18 May 2024. S148. (doi: 10.1016/j.hpb.2024.03.269)

Bryce, Adam ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Dreyer, Stephan, Dolan, Ross ORCID logoORCID: https://orcid.org/0000-0002-5272-5906, Froeling, Fieke ORCID logoORCID: https://orcid.org/0000-0002-8653-8164 and Chang, David ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2024) Host phenotypic adversity independently predicts progression to resection in neoadjuvantly-treated pancreatic cancer. 42nd Congress of the European Society of Surgical Oncology, Florence, Italy, 25-27 Oct 2023. (doi: 10.1016/j.ejso.2023.107753)

Dreyer, Stephan, Bryce, Adam ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Australian Pancreatic Cancer Genome Initiative, Biankin, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, Nigel ORCID logoORCID: https://orcid.org/0000-0002-9552-4725 and Chang, David ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2024) The clinical and molecular landscape of early onset pancreatic cancer. 42nd Congress of the European Society of Surgical Oncology, Florence, Italy, 25-27 Oct 2023. (doi: 10.1016/j.ejso.2023.107348)

2023

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

2022

Bryce, Adam S. ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Dreyer, Stephan B., Froeling, Fieke E.M. ORCID logoORCID: https://orcid.org/0000-0002-8653-8164 and Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2022) Exploring the biology of cancer-associated fibroblasts in pancreatic cancer. Cancers, 14(21), 5302. (doi: 10.3390/cancers14215302) (PMID:36358721) (PMCID:PMC9659154)

Khan, Khurram S. ORCID logoORCID: https://orcid.org/0000-0002-8304-5970, Gall, Lewis S., Dreyer, Stephan, McCollum, Catherine, Chuntamongkol, Rongkagorn, Craig, Carol, MacKay, Colin, Macdonald, Andrew and Forshaw, Matthew (2022) Stage migration in newly diagnosed oesophagogastric cancer during the first wave of the COVID-19 pandemic. British Journal of Surgery, 109(8), pp. 773-774. (doi: 10.1093/bjs/znac112) (PMID:35616120)

Dreyer, Stephan B., Upstill-Goddard, Rosie, Legrini, Assya ORCID logoORCID: https://orcid.org/0000-0001-5377-3048, Biankin, Andrew V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, Nigel B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725 and Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2022) Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence. Gastroenterology, 162(1), 320-324.e4. (doi: 10.1053/j.gastro.2021.09.022) (PMID:34534536) (PMCID:PMC8721486)

Dreyer, S., Upstill-Goddard, R., Legrini, A. ORCID logoORCID: https://orcid.org/0000-0001-5377-3048, Biankin, A. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, N. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725 and Chang, D. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2022) Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. 15th World Congress of the International Hepato-Pancreato-Biliary Association, New York, USA, 30 Mar - 02 Apr 2022. S44-S45. (doi: 10.1016/j.hpb.2022.05.086)

2021

Casolino, R. et al. (2021) Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Annals of Oncology, 32(2), pp. 183-196. (doi: 10.1016/j.annonc.2020.11.013) (PMID:33248227) (PMCID:PMC7840891)

Dreyer, S. B. et al. (2021) Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology, 160(1), pp. 362-377. (doi: 10.1053/j.gastro.2020.09.043) (PMID:33039466) (PMCID:PMC8167930)

2020

Moekotte, A. L. et al. (2020) Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma. Annals of Surgery, 272(6), pp. 1086-1093. (doi: 10.1097/SLA.0000000000003177) (PMID:30628913)

Moekotte, A. L. et al. (2020) Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma. European Journal of Surgical Oncology, 46(9), pp. 1717-1726. (doi: 10.1016/j.ejso.2020.04.011) (PMID:32624291)

Dreyer, S. B. et al. (2020) Precision oncology in surgery: patient selection for operable pancreatic cancer. Annals of Surgery, 272(2), pp. 366-376. (doi: 10.1097/SLA.0000000000003143) (PMID:32675551) (PMCID:PMC7373491)

Moekotte, A.L. et al. (2020) Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. British Journal of Surgery, 107(9), pp. 1171-1182. (doi: 10.1002/bjs.11555) (PMID:32259295)

Brunton, H. et al. (2020) HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Reports, 31(6), 107625. (doi: 10.1016/j.celrep.2020.107625) (PMID:32402285)

Dreyer, S.B., Jamieson, N.B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Cooke, S.L. ORCID logoORCID: https://orcid.org/0000-0002-0955-0346, Valle, J.W., McKay, C.J., Biankin, A.V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2020) PRECISION-Panc: the next generation therapeutic development platform for pancreatic cancer. Clinical Oncology, 32(1), pp. 1-4. (doi: 10.1016/j.clon.2019.07.011) (PMID:31378449)

Dreyer, S.B., Jamieson, N.B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Morton, J.P. ORCID logoORCID: https://orcid.org/0000-0001-5766-9141, Sansom, O.J. ORCID logoORCID: https://orcid.org/0000-0001-9540-3010, Biankin, A.V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2020) Pancreatic cancer: from genome discovery to PRECISION-Panc. Clinical Oncology, 32(1), pp. 5-8. (doi: 10.1016/j.clon.2019.08.007) (PMID:31522943)

2019

Halbrook, C. J. et al. (2019) Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metabolism, 29(6), 1390-1399.e6. (doi: 10.1016/j.cmet.2019.02.001) (PMID:30827862) (PMCID:PMC6602533)

Dreyer, S. B. et al. (2019) Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Chinese Clinical Oncology, 8(2), 16. (doi: 10.21037/cco.2019.04.06) (PMID:31070037)

2018

Dreyer, S.B., Jamieson, N.B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Upstill-Goddard, R., Bailey, P.J. ORCID logoORCID: https://orcid.org/0000-0002-0857-2041, McKay, C.J., Australian Pancreatic Cancer Genome Initiative, Biankin, A.V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2018) Defining the molecular pathology of pancreatic body and tail adenocarcinom. British Journal of Surgery, 105(2), e183-e191. (doi: 10.1002/bjs.10772) (PMID:29341146) (PMCID:PMC5817249)

2017

Dreyer, Stephan B., Powell, Arfon G.M.T., McSorley, Stephen T. ORCID logoORCID: https://orcid.org/0000-0002-5459-8445, Waterston, Ashita, Going, James J., Edwards, Joanne ORCID logoORCID: https://orcid.org/0000-0002-7192-6906, McMillan, Donald C. ORCID logoORCID: https://orcid.org/0000-0003-4260-5334 and Horgan, Paul G. ORCID logoORCID: https://orcid.org/0000-0001-5557-7905 (2017) The pretreatment systemic inflammatory response is an important determinant of poor pathologic response for patients undergoing neoadjuvant therapy for rectal cancer. Annals of Surgical Oncology, 24(5), pp. 1295-1303. (doi: 10.1245/s10434-016-5684-3) (PMID:27873100)

Dreyer, Stephan B., Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078, Bailey, Peter ORCID logoORCID: https://orcid.org/0000-0002-0857-2041 and Biankin, Andrew V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 (2017) Pancreatic cancer genomes: implications for clinical management and therapeutic development. Clinical Cancer Research, 23(7), pp. 1638-1646. (doi: 10.1158/1078-0432.CCR-16-2411) (PMID:28373362)

This list was generated on Sun Jun 15 14:58:13 2025 BST.
Jump to: Articles | Conference or Workshop Item
Number of items: 24.

Articles

Dreyer, Stephan B., Beer, Philip, Hingorani, Sunil R. and Biankin, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 (2025) Improving outcomes of patients with pancreatic cancer. Nature Reviews Clinical Oncology, 22(6), pp. 439-456. (doi: 10.1038/s41571-025-01019-9) (PMID:40329051)

Herbert, Katharine J. ORCID logoORCID: https://orcid.org/0000-0001-9437-0253, Upstill-Goddard, Rosie, Dreyer, Stephan B., Rebus, Selma, Pilarsky, Christian, Debabrata, Mukhopadhyay, Lord, Christopher J., Biankin, Andrew V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Froeling, Fieke E.M. ORCID logoORCID: https://orcid.org/0000-0002-8653-8164 and Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2025) Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma. British Journal of Cancer, (doi: 10.1038/s41416-025-03051-z) (Early Online Publication)

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

Bryce, Adam S. ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Dreyer, Stephan B., Froeling, Fieke E.M. ORCID logoORCID: https://orcid.org/0000-0002-8653-8164 and Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2022) Exploring the biology of cancer-associated fibroblasts in pancreatic cancer. Cancers, 14(21), 5302. (doi: 10.3390/cancers14215302) (PMID:36358721) (PMCID:PMC9659154)

Khan, Khurram S. ORCID logoORCID: https://orcid.org/0000-0002-8304-5970, Gall, Lewis S., Dreyer, Stephan, McCollum, Catherine, Chuntamongkol, Rongkagorn, Craig, Carol, MacKay, Colin, Macdonald, Andrew and Forshaw, Matthew (2022) Stage migration in newly diagnosed oesophagogastric cancer during the first wave of the COVID-19 pandemic. British Journal of Surgery, 109(8), pp. 773-774. (doi: 10.1093/bjs/znac112) (PMID:35616120)

Dreyer, Stephan B., Upstill-Goddard, Rosie, Legrini, Assya ORCID logoORCID: https://orcid.org/0000-0001-5377-3048, Biankin, Andrew V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, Nigel B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725 and Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2022) Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence. Gastroenterology, 162(1), 320-324.e4. (doi: 10.1053/j.gastro.2021.09.022) (PMID:34534536) (PMCID:PMC8721486)

Casolino, R. et al. (2021) Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Annals of Oncology, 32(2), pp. 183-196. (doi: 10.1016/j.annonc.2020.11.013) (PMID:33248227) (PMCID:PMC7840891)

Dreyer, S. B. et al. (2021) Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology, 160(1), pp. 362-377. (doi: 10.1053/j.gastro.2020.09.043) (PMID:33039466) (PMCID:PMC8167930)

Moekotte, A. L. et al. (2020) Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma. Annals of Surgery, 272(6), pp. 1086-1093. (doi: 10.1097/SLA.0000000000003177) (PMID:30628913)

Moekotte, A. L. et al. (2020) Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma. European Journal of Surgical Oncology, 46(9), pp. 1717-1726. (doi: 10.1016/j.ejso.2020.04.011) (PMID:32624291)

Dreyer, S. B. et al. (2020) Precision oncology in surgery: patient selection for operable pancreatic cancer. Annals of Surgery, 272(2), pp. 366-376. (doi: 10.1097/SLA.0000000000003143) (PMID:32675551) (PMCID:PMC7373491)

Moekotte, A.L. et al. (2020) Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. British Journal of Surgery, 107(9), pp. 1171-1182. (doi: 10.1002/bjs.11555) (PMID:32259295)

Brunton, H. et al. (2020) HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Reports, 31(6), 107625. (doi: 10.1016/j.celrep.2020.107625) (PMID:32402285)

Dreyer, S.B., Jamieson, N.B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Cooke, S.L. ORCID logoORCID: https://orcid.org/0000-0002-0955-0346, Valle, J.W., McKay, C.J., Biankin, A.V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2020) PRECISION-Panc: the next generation therapeutic development platform for pancreatic cancer. Clinical Oncology, 32(1), pp. 1-4. (doi: 10.1016/j.clon.2019.07.011) (PMID:31378449)

Dreyer, S.B., Jamieson, N.B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Morton, J.P. ORCID logoORCID: https://orcid.org/0000-0001-5766-9141, Sansom, O.J. ORCID logoORCID: https://orcid.org/0000-0001-9540-3010, Biankin, A.V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2020) Pancreatic cancer: from genome discovery to PRECISION-Panc. Clinical Oncology, 32(1), pp. 5-8. (doi: 10.1016/j.clon.2019.08.007) (PMID:31522943)

Halbrook, C. J. et al. (2019) Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metabolism, 29(6), 1390-1399.e6. (doi: 10.1016/j.cmet.2019.02.001) (PMID:30827862) (PMCID:PMC6602533)

Dreyer, S. B. et al. (2019) Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Chinese Clinical Oncology, 8(2), 16. (doi: 10.21037/cco.2019.04.06) (PMID:31070037)

Dreyer, S.B., Jamieson, N.B. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Upstill-Goddard, R., Bailey, P.J. ORCID logoORCID: https://orcid.org/0000-0002-0857-2041, McKay, C.J., Australian Pancreatic Cancer Genome Initiative, Biankin, A.V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2018) Defining the molecular pathology of pancreatic body and tail adenocarcinom. British Journal of Surgery, 105(2), e183-e191. (doi: 10.1002/bjs.10772) (PMID:29341146) (PMCID:PMC5817249)

Dreyer, Stephan B., Powell, Arfon G.M.T., McSorley, Stephen T. ORCID logoORCID: https://orcid.org/0000-0002-5459-8445, Waterston, Ashita, Going, James J., Edwards, Joanne ORCID logoORCID: https://orcid.org/0000-0002-7192-6906, McMillan, Donald C. ORCID logoORCID: https://orcid.org/0000-0003-4260-5334 and Horgan, Paul G. ORCID logoORCID: https://orcid.org/0000-0001-5557-7905 (2017) The pretreatment systemic inflammatory response is an important determinant of poor pathologic response for patients undergoing neoadjuvant therapy for rectal cancer. Annals of Surgical Oncology, 24(5), pp. 1295-1303. (doi: 10.1245/s10434-016-5684-3) (PMID:27873100)

Dreyer, Stephan B., Chang, David K. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078, Bailey, Peter ORCID logoORCID: https://orcid.org/0000-0002-0857-2041 and Biankin, Andrew V. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597 (2017) Pancreatic cancer genomes: implications for clinical management and therapeutic development. Clinical Cancer Research, 23(7), pp. 1638-1646. (doi: 10.1158/1078-0432.CCR-16-2411) (PMID:28373362)

Conference or Workshop Item

Boey, A., Bryce, A. ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Dickson, E., Coats, M., McKay, C., Jamieson, N. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725, Chang, D. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078, Holroyd, D. and Dreyer, S. (2024) The Impact of Pre-operative Indeterminate Lung Nodules in the Surgical Management of Pancreatic Ductal Adenocarcinoma. 16th World Congress of the International Hepato-Pancreato-Biliary Association, Cape Town, South Africa, 15-18 May 2024. S148. (doi: 10.1016/j.hpb.2024.03.269)

Bryce, Adam ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Dreyer, Stephan, Dolan, Ross ORCID logoORCID: https://orcid.org/0000-0002-5272-5906, Froeling, Fieke ORCID logoORCID: https://orcid.org/0000-0002-8653-8164 and Chang, David ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2024) Host phenotypic adversity independently predicts progression to resection in neoadjuvantly-treated pancreatic cancer. 42nd Congress of the European Society of Surgical Oncology, Florence, Italy, 25-27 Oct 2023. (doi: 10.1016/j.ejso.2023.107753)

Dreyer, Stephan, Bryce, Adam ORCID logoORCID: https://orcid.org/0000-0003-0253-9723, Australian Pancreatic Cancer Genome Initiative, Biankin, Andrew ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, Nigel ORCID logoORCID: https://orcid.org/0000-0002-9552-4725 and Chang, David ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2024) The clinical and molecular landscape of early onset pancreatic cancer. 42nd Congress of the European Society of Surgical Oncology, Florence, Italy, 25-27 Oct 2023. (doi: 10.1016/j.ejso.2023.107348)

Dreyer, S., Upstill-Goddard, R., Legrini, A. ORCID logoORCID: https://orcid.org/0000-0001-5377-3048, Biankin, A. ORCID logoORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, N. ORCID logoORCID: https://orcid.org/0000-0002-9552-4725 and Chang, D. ORCID logoORCID: https://orcid.org/0000-0002-4821-3078 (2022) Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. 15th World Congress of the International Hepato-Pancreato-Biliary Association, New York, USA, 30 Mar - 02 Apr 2022. S44-S45. (doi: 10.1016/j.hpb.2022.05.086)

This list was generated on Sun Jun 15 14:58:13 2025 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • The role of cancer associated fibroblast heterogeneity in determining metastatic patterns in pancreatic and oesophageal adenocarcinoma
    Office of the Chief Scientific Adviser
    2022 - 2024
     
  • The role of tumour microenvironment heterogeneity in determining metastatic patterns in pancreatic and oesophagogastric adenocarcinoma
    Rosetrees Trust
    2022 - 2024
     
  • The role of tumour microenvironment heterogeneity in determining metastatic patterns in pancreatic and oesophagogastric adenocarcinoma
    The Stoneygate Trust
    2022 - 2024
     
  • The role of tumour microenvironment heterogeneity in determining metastatic patterns in oesophago-gastric adenocarcinoma
    Tenovus Scotland
    2021 - 2023
     
  • Characterising the immune landscape of molecular subtypes of pancreatic ductal adenocarcinoma
    Cancer Research UK
    2020 - 2022